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Available online at www.sciencedirect.comInflammasomes are protein complexes that form in response to
pathogen-derived or host-derived stress signals. Their
activation leads to the production of inflammatory cytokines
and promotes a pyrogenic cell death process. The massive
release of inflammatory mediators that follows inflammasome
activation is a key event in alarming innate immune cells.
Growing evidence also highlights the role of inflammasome-
dependent cytokines in shaping the adaptive immune
response, as exemplified by the capacity of IL-1b to support
Th17 responses, or by the finding that IL-18 evokes antigen-
independent IFN-g secretion by memory CD8+ T cells. A
deeper understanding of these mechanisms and on how to
manipulate this powerful inflammatory system therefore
represents an important step forward in the development of
improved vaccine strategies.
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Introduction
Sensing of different pathogen-associated molecular pat-
terns (PAMPs) or danger-associated molecular patterns
(DAMPs) can lead to activation of inflammasomes [1,2].
The huge inflammatory potential liberated upon inflam-
masome assembly is a basic defense mechanism
employed to control different infections and its central
role in innate immune responses has been largely demon-
strated over the past years. Mounting evidence suggests
that inflammasomes might be important for adaptive
immune responses as well. We will therefore present
here the current understanding on how inflammasomes
tailor adaptive immune responses.
Inflammasomes: intracellular platforms for
caspase-1 activation
Inflammasomes are intracellular caspase-1 activating
multiprotein complexes that are induced by different
PAMPs or DAMPs (as schematically represented inPlease cite this article in press as: Dostert C, et al.: Innate and adaptive effects of inflammasome
www.sciencedirect.com Figure 1; for general review on inflammasome function,
see [1,2]). They are formed by association of NOD-like
receptor (NLR) family members with the adaptor protein
apoptosis speck protein with caspase recruitment domain
(ASC) and procaspase-1 through homotypic domain inter-
actions. Their formation results in the proteolytic acti-
vation of caspase-1, which in turn processes different
substrates. Several NLRs such as NLR family, pyrin
domain containing 1 (NLRP1), NLRP3 and NLR family,
caspase recruitment domain containing 4 (NLRC4) have
been shown to form functional inflammasomes in response
to a wide array of stimuli. Furthermore, absent in mela-
noma 2 (AIM2), a member of the PYHIN family, can
recruit ASC and caspase-1 in response to double-stranded
DNA [2].
Regulation of caspase-1-dependent cytokines
Active caspase-1 has several known targets, including
cytokines from the interleukin (IL)-1 family. In addition,
its activity is implicated in the unconventional secretion
of other danger signals, such as the alarmin high-mobility
group box 1 (HMGB1), and in a process of inflammatory
cell death called pyroptosis [3–5].
IL-1b and IL-18, the two best-characterized inflamma-
some-dependent cytokines, are cleaved by caspase-1 from
their inactive intracellular precursors, pro-IL-1b and pro-
IL-18 [6]. IL-1a, another IL-1 family member, does not
however require cleavage for its activity. It is often secreted
concomitantly with IL-1b, though its release in response to
certain stimuli and in vivo can be independent of the
inflammasome [7,8]. Since IL-1a and IL-1b both signal
through the IL-1R complex, the contribution in vivo of
both cytokines is not always clear. It is therefore important
to keep in mind that dependency on IL-1R does not yet
imply caspase-1 dependency. IL-18 signals via a distinct
receptor, the IL-18R, which belongs to the IL-1 receptor
superfamily and is structurally very similar to IL-1R.
In contrast to IL-1, whose expression requires an NF-kB
activating signal, IL-18 mRNA is considered to be con-
stitutively expressed in many cell types and therefore
largely regulated through caspase-1-dependent cleavage
[9]. However, LPS treatment of macrophages strongly
augments IL-18 transcript abundance [10]. Notably, a
PU.1 and an interferon consensus sequence binding
protein (ICSBP) binding site have been located in the
promoter of IL-18, which suggests its upregulation also by
IFNs [11,12]. As type I IFNs can significantly reduce pro-
IL-1a and pro-IL-1b levels [13], it is plausible that IFNs
shift the balance of the two major caspase-1 substrates in
favor of pro-IL-18.s on T cell responses, Curr Opin Immunol (2013), http://dx.doi.org/10.1016/j.coi.2013.02.008
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Schematic overview of the best-characterized inflammasomes and their main activators.Main effects of IL-1b and IL-18 on T helper cell
polarization
The most prominent feature of IL-1b with regard to the
adaptive immune response is to favor T helper type 17Please cite this article in press as: Dostert C, et al.: Innate and adaptive effects of inflammasome
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Effects of IL-1 and IL-18 in the polarization of T cell responses. IL-1b and
IL-18 are processed into their active form by the inflammasome and can
differentially influence the polarization of T cells. Whereas IL-18 supports
Th1 differentiation in synergy with IL-12, IL-1b promotes Th17
differentiation. IL-1a shares with IL-1b this ability, but its secretion can
be independent of the inflammasome.
Current Opinion in Immunology 2013, 25:1–7 (Th17) differentiation (as summarized in Figure 2) [14–
16]. This lymphocyte subset secretes IL-17 and partici-
pates in host defense against extracellular bacteria and
fungi, but is also involved in autoimmunity.
IL-18 acts instead as an amplifier of IFN-g production by
Th1 cells (Figure 2) [11]. IL-18R is poorly expressed on
naı¨ve T cells, but is upregulated upon priming, allowing
enhanced Th1 polarization of activated T lymphocytes.
Furthermore, IL-18R expression is increased following
exposure to IL-12, the major Th1-polarizing cytokine.
IL-18, in turn, helps induce the IL-12 high affinity re-
ceptor, establishing a feed-forward Th1-amplifying loop
[11,17]. Surprisingly, in the absence of a Th1-polarizing
environment, IL-18 can promote the differentiation of
Th2 cells, a CD4+ T cell subset dominating allergic
responses and characterized by the expression of IL-4
and IL-13 [11,17,18].
Although the effects of IL-1b and IL-18 on adaptive
immune cells have been well characterized, the in vivo
relevance of inflammasomes in adaptive immune
responses remains more elusive. The following sections
will therefore summarize the recent data on their in vivo
effects and pinpoint the drawbacks of the models that
have been used.
Inflammasomes and adjuvanticity
Inflammasome activation and adjuvants
It was long known that DAMPs can activate dendritic
cells (DCs), thereby favoring T cell priming. Uric acids on T cell responses, Curr Opin Immunol (2013), http://dx.doi.org/10.1016/j.coi.2013.02.008
www.sciencedirect.com
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danger signal released from dying cells that acts as an
efficient T cell adjuvant [19]. Interestingly, DAMPs
such as uric acid, ATP, or mitochondrial DNA activate
the NLRP3 inflammasome, raising the question on
whether or not its activity is important for T cell
priming under such conditions. Indeed, uric acid
crystals were shown to promote Th17 responses in an
ASC-dependent and caspase-1-dependent manner
when applied subcutaneously [20]. However, in a
uric acid-mediated asthma model Th2-polarized
responses proceeded independently of the inflamma-
some [21].
This is reminiscent of what has been observed for alum, a
clinically approved adjuvant that is routinely used in
human vaccines. Alum has unanimously been shown to
activate the NLRP3 inflammasome in vitro, but the in
vivo role of the inflammasome in alum-induced adjuvan-
ticity remains controversial [22–26]. IL-18 and IL-1
preferentially drive Th1/Th17 responses, whereas alum
rather polarizes Th2 type immunity, which — by some
groups — was found to be unaltered in the absence of
caspase-1 or Nlrp3 [24,25]. Along this line, whereas IL-1
signaling and inflammasome activity have been impli-
cated in allergic reactions, the importance of the latter in
the establishment of such Th2 responses has not been
unambiguously delineated [26–28]. Therefore, the
definitive role of the NLRP3 inflammasome in adjuvan-
ticity might occur through indirect mechanisms, be
strongly influenced by the context, and still remains to
be clarified.
Of note, it has been shown that tumor cells treated with
chemotherapeutic agents can act as effective adjuvants to
prime antitumor T cell responses through release of ATP
and subsequent P2X7-dependent inflammasome acti-
vation [29]. As illustrated hereafter, additional implica-
tions of inflammasomes in the development of adaptive
immunity come from the study of naturally occurring
immune responses.Please cite this article in press as: Dostert C, et al.: Innate and adaptive effects of inflammasome
Table 1
Implications of inflammasomes in the development of adaptive imm
diseases (n.a., not assessed; arrows in brackets indicate a mild effec
Disease/infection model IFN-g (Th1) IL-17 (Th17)
CAPS !, (%) % 
EAE (inact. M. tuberculosis/pertussis toxin) & & 
M. tuberculosis & n.a. 
B. pertussis (adenylate cyclase toxin) (&), n.a. & 
C. albicans & & 
L. pneumophila n.a. & 
n.a. % 
S. mansoni & & 
H. pylori ! (%) 
! ! 
www.sciencedirect.com Lessons from autoimmune and autoinflammatory
conditions
Recent reports link the inflammasome to Multiple
Sclerosis (MS), a demyelinating inflammatory disease
of the central nervous system, where autoreactive T
cells target oligodendrocytes [30,31]. IL-1 signaling has
been implicated in the development of MS, a
Th1-driven and Th17-driven pathology [30–32].
Inflammasome-deficient mice are protected from dis-
ease progression in experimental autoimmune encepha-
lomyelitis (EAE), a mouse model of MS (Table 1) [33–
36]. The exact function of the inflammasome in this
process is however unclear, since two recent reports
describe the implication of Nlrp3 and ASC in EAE
progression [34,36], whereas another study finds an
inflammasome-independent role for ASC [35]. These
divergent findings could be due to differences in the
immunization protocols used for EAE induction, as
suggested in [33,36].
A second example is cryopyrin-associated periodic syn-
dromes (CAPS), human disorders which present with
recurrent fever and inflammation and are in many cases
due to gain-of-function mutations in NLRP3 [37].
Knockin (KI) mice harboring constitutively active
NLRP3 mutations have been established and recapitu-
late several aspects of the human disease, such as skin and
systemic illness together with increased IL-1b production
in the myeloid compartment [38,39]. The NLRP3-
R258W KI mouse develops skin inflammation with neu-
trophil infiltration and predominant Th17 differentiation,
whereas in the NLRP3-A350V KI mouse the autoinflam-
matory process was shown to be T and B cell-indepen-
dent. The reason for these different observations in the
two KI models remains unclear. Interestingly, a recent
study showed increased IL-17 serum levels as well as
Th17 frequency in CAPS patients, which could be
reduced by blocking IL-1b in vivo, suggesting that
inflammasome-derived IL-1b is important in the differ-
entiation of Th17 in human autoinflammatory conditions
(Table 1) [40].s on T cell responses, Curr Opin Immunol (2013), http://dx.doi.org/10.1016/j.coi.2013.02.008
une responses in autoinflammatory, autoimmune, and infectious
t).
 Disease/experimental model Reference
CAPS patients, NLRP3-R258W KI [40,38]
caspase-1/, Asc/, Nlrp3/, IL-18/, IL-1RI/ [30,33–36]
AIM2/ [46]
IL-1RI/, caspase-1 inhibitor [43]
Asc/, caspase-1/ [42]
caspase-1/, IL-1RI/, Nlrc4/ [45]
IL-18/
Nlrp3/, Asc/ [44]
caspase-1/, IL-18/ [41]
IL-1RI/
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Inflammasome-derived cytokines elicit non-cognate memory T cell
effector functions. In the above-depicted infectious models, it was
shown that inflammasome-derived IL-18 drives IFN-g production by
memory CD8+ T cells, even in the absence of TCR stimulation. Similarly,
IL-1 together with IL-23 can elicit IL-17 secretion by activated CD4+ and
CD8+ T cells in an antigen-independent manner. Furthermore, other
lymphocyte subsets such as NK, NKT, or gd T cells can respond to IL-18
and IL-1 contributing to the innate production of IFN-g and IL-17.Inflammasomes and T cell responses in infections
IL-1 has been shown to promote Th17 polarization in the
context of different types of infections (Table 1)
[41,42,43,44,45,46]. The use of knockout mouse
strains highlighted the role of caspase-1 and ASC in
Th17 priming during Candida albicans infection [42].
C. albicans-induced IL-1b drives the differentiation of
Th17 cells secreting IL-17 alongside with IFN-g [47].
In line with this observation, the absence of IL-1 often
leads to decreased numbers of IL-17-producing as well as
IFN-g-producing cells [41,42,43,44]. Moreover, IL-1
can promote T cell proliferation, and its suppressive
effects on regulatory T cells and IL-10 production by
T cells provide a mechanistic interpretation for the for-
mer observation [47,48]. It is therefore not surprising
that in some infectious models, inflammasome deficiency
leads to a generalized reduction of T cell responses
[42,44]. In addition, it has recently been demonstrated
that upon influenza A infection, IL-1R signaling in DCs is
necessary to promote CD8+ T cell responses, illustrating
how paracrine IL-1 can contribute to mature DCs [49].
Since this study was based on IL-1RI-knockout mice, the
precise contribution by inflammasomes, however,
remains to be determined.
IL-1RI-deficient animals infected with Bordetella pertussis
showed decreased protection and diminished Th17
responses [43]. Yet, because both IL-1b and IL-1a
promote Th17 polarization, the contribution by the
inflammasome in the priming phase was shown using a
selective caspase-1 inhibitor. The use of Nlrc4- and Nlrp3-
further suggested inflammasome relevance in inducing
Th17 responses upon Legionella pneumophila and Schisto-
soma mansoni infection, respectively [44,45]. In con-
trast, caspase-1 ablation did not reduce IL-17 production
in the context of Helicobacter pylori infection, while IL-18
deficiency promoted it, pinpointing the relevance of
inflammasome substrates in modulating the adaptive
immune response [41].
IL-18 has been shown to promote IFN-g production in
several infectious models, including Propionibacterium
acnes, Mycobacterium bovis, Leishmania major, and the
intracellular fungal parasite Cryptococcus neoformans
[11,50]. However, it was noticed early on that the effects
of IL-18 on Th1 polarization are different from those of
IL-12. While IL-12 is a crucial factor for Th1 polarization,
IL-18 only has the ability of acting on IL-12-primed cells
to strengthen their Th1 differentiation [50].
Infectious models make a strong case for the in vivo Th17/
Th1 polarizing properties of the inflammasome substrates
IL-1b and IL-18. As discussed in the next section, IL-18
also owns the surprising ability to elicit IFN-g secretion
by memory T cells in the absence of antigenic-triggering,
questioning — in some experimental settings — its fac-
tual contribution to bona fide Th1 polarization.Please cite this article in press as: Dostert C, et al.: Innate and adaptive effects of inflammasome
Current Opinion in Immunology 2013, 25:1–7 Inflammasome and non-cognate lymphocyte activation
Recent findings highlight inflammasome importance in
mediating non-cognate IFN-g release, thereby ‘adjuvat-
ing’ immune responses (illustrated in Figure 3). Salmo-
nella Typhimurium infection or injection of heat-
inactivated lysates stimulated the release of IFN-g by
splenic memory cytotoxic T cells of unrelated specificity
[51]. This effect, as shown by the use of knockout mice,
was mediated by IL-18 released upon NLRC4 inflamma-
some activation in DCs as early as two hours after the
insult. Importantly, non-cognate CD8+ T lymphocyte-
derived IFN-g contributed to the management of the
infection [51]. Similarly, splenic natural killer (NK) and
memory CD8+ T cells produced innate IFN-g secretion
starting from eight hours after Listeria monocytogenes in-
fection [52]. Inflammatory monocytes were the key cells
eliciting, in a caspase 1-dependent manner, lymphocyte-
derived IFN-g release, suggesting that different cell
subsets could contribute to IL-18 secretion either
sequentially or depending on the infectious agent. In
addition, an analogous mechanism takes place in draining
lymph nodes where, upon Pseudomonas aeruginosa infec-
tion, the major source of IL-18 are subcapsular sinus
macrophages, which are strategically positioned to cap-
ture invading pathogens and particles [53]. Innate IFN-
g secretion by CD8+ T cells and other lymphocyte sub-
sets was observed upon additional bacterial, viral, and
protozoan infections, underlining how broadly thiss on T cell responses, Curr Opin Immunol (2013), http://dx.doi.org/10.1016/j.coi.2013.02.008
www.sciencedirect.com
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[51,52,53].
Recent studies attributed not only to IL-18, but also to
IL-1b, in combination with IL-23 the ability to stimulate
IFN-g as well as IL-17 secretion without need for T cell
receptor (TCR) triggering [30,54]. These results further
suggest that inflammasome-driven innate lymphocyte
functions could be relevant to antifungal and auto-
immune responses.
An environment rich in IFN-g coinciding with antigen
presentation to naı¨ve T lymphocytes favors the priming of
robust Th1 responses. The advantage of evoking IFN-g
production by lymphocytes could, therefore, be twofold: it
helps to activate innate immune cells to control pathogen
spread during primary encounter and the development of a
Th1-polarized memory response for future challenges.
Concluding remarks
While emerging evidence highlights the importance of
inflammasome-derived IL-18 to elicit innate IFN-g
secretion by lymphocytes, its impact on the concomitant
priming of antigen-specific T cells has not been explicitly
addressed. Furthermore, to carefully evaluate inflamma-
some relevance in the priming and polarization of adap-
tive immune responses, the contribution of the different
inflammasomes, their substrates, and IL-1a should be
individually addressed. The current understanding is in
fact strongly hindered by the lack of such complete
information. Hopefully, future work will enable us to
better define the role of each of these players.
Nonetheless, the key role of IL-1 in supporting Th17
polarization and the importance of IL-18 in promoting
Th1-tailored responses as well as non-cognate IFN-g
release are supported by multiple lines of evidence.
The divergent functions of IL-1b and IL-18 in shaping
adaptive immunity render the possibility of controlling
these two substrates appealing, particularly for vaccina-
tion purposes. Favoring IL-18 production represents a
promising way to achieve protective Th1 responses. Type
I IFNs are known to inhibit pro-IL-1 synthesis and
activity of the canonical NLRP3 inflammasome, while
they might promote pro-IL-18 [11,13,32,55]. Thus, an
attractive adjuvant could combine an inducer of type I
IFN to an activator of an alternative inflammasome, such
as the AIM2 inflammasome [2], maybe in the form of
nucleic acids or safe viral agents.
The last decade witnessed the discovery of inflamma-
somes as key players of the innate immune response and
led to improved clinical treatments for autoinflammatory
disorders. The role of inflammasomes in the adaptive
immune response has only recently emerged and anticip-
ates a better control of adaptive immunity over the
coming years.Please cite this article in press as: Dostert C, et al.: Innate and adaptive effects of inflammasome
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